Keynote: The Role of Imaging to Augment Primary Prevention • After this session, participants should be able to discuss how cardiac imaging contributes to early detection, risk assessment, and disease monitoring. Session 1: Critical Care Cardiology At the conclusion of this session, participants should be able to: 1. Diagnose and stage cardiogenic shock to guide early hemodynamic assessment and initial management. 2. Compare available mechanical circulatory support devices by hemodynamic effect, patient selection, and complication profile. 3. Identify patients with refractory shock who may benefit from VA-ECMO, including candidacy, timing of escalation, and management. Session 2: Pulmonary Embolism At the conclusion of this session, participants should be able to: 1. Apply the 2026 Acute Pulmonary Embolism Guideline to risk-stratify patients with acute PE and select evidence-based treatment strategies, including anticoagulation, advanced therapies, and appropriate level of care. 2. Evaluate indications for invasive treatment of acute pulmonary embolism and select appropriate catheter-based or surgical interventions based on patient risk stratification, hemodynamic status, and available evidence. 3. Diagnose chronic thromboembolic pulmonary hypertension (CTEPH) and develop an evidence-based management plan incorporating pulmonary endarterectomy, balloon pulmonary angioplasty, and medical therapy. Technology Keynote • AI In Cardiology: Separating Facts From Fads and Science From Science Fiction o After this presentation, participants should be prepared to utilize emerging AI tools responsibly to improve their ability to provide the best care for patients. Session 3: CKM Connection At the conclusion of this session, participants should be able to: 1. Describe the evolution of cardiovascular care within the cardiovascular-kidney-metabolic (CKM) framework. 2. Apply evidence-based strategies for the use of SGLT2 inhibitors and nonsteroidal mineralocorticoid receptor antagonists (ns-MRAs) to reduce cardiovascular and kidney complications in patients with cardiovascular-kidney-metabolic (CKM) syndrome. 3. Integrate evidence-based GLP-1 receptor agonist therapy into the management of patients with diabetes and cardiovascular disease to improve cardiovascular outcomes and address associated metabolic risk factors. Session 4: Great Debates & Potpurri At the conclusion of this session, participants should be able to: 1. Compare surgical and transcatheter approaches to aortic valve replacement in low-risk patients with aortic stenosis. 2. Discuss the potential benefits and limitations of coronary artery calcium scoring in broad patient populations. 3. Describe the role of multimodality imaging in the evaluation of Takotsubo cardiomyopathy. FIT Jeopardy • In this session, both competitors and attendees will answer Cardiovascular quiz questions, in the style of the game Jeopardy! Questions will range from recalling Cardiovascular facts, case-based analysis, and identifying disease in imaging slides and videos.